Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vivus Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 18
» View wsbt.com items only
    Oct 28, 2009 | Los Angeles Times

  1. Obesity drugs lumber toward marketplace

    Booster Shots
    About this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
    2. May 24, 2013 |Story| Reuters

  2. Novo obesity drug could launch in U.S. end 2014

    Reuters
    COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. The world's biggest insulin...

    Tags: Deutsche Bank AG, Qsymia, Obesity, Arena Pharmaceuticals, Inc., New Products

    3. May 23, 2013 |Story| Reuters

  3. Denner added as nominee to Vivus board by activist investor

    Reuters
    By Bill Berkrot May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and two others to its slate of...

    Tags: Economy, Business and Finance, Board of Directors, Carl Icahn, Qsymia, ImClone Systems Incorporated

    4. May 9, 2013 |Story| Reuters

  4. ANALYSIS-A hard day to be a short-seller, one of many this year

    Reuters
    By Ryan Vlastelica NEW YORK, May 9 (Reuters) - Three long-time favorites of the short-selling crowd are making those investors eat crow, as Tesla, Barnes & Noble and Green Mountain Coffee are racking up big gains, making an already painful year for...

    Tags: Dendreon Corporation, Microsoft Corporation, Groupon, Inc., JC Penney Company Inc., Thomson Corporation

    5. May 8, 2013 |Story| Chicago Tribune

  5. The day ahead in business May 8

    Reports: MBA mortgage index for week ended May 4, 6:30 a.m.; Crude inventories for week ended May 4, 9:30 a.m.
    Reports: MBA mortgage index for week ended May 4, 6:30 a.m.; Crude inventories for week ended May 4, 9:30 a.m. Local earnings: CF Industries Holdings Inc., Groupon Inc., Manitex International Inc., Middleby Corp., MYR Group Inc., Nanosphere Inc.,...

    Tags: Activision Blizzard, Inc., AOL LLC, Green Mountain Coffee Roasters, Inc., AptarGroup Incorporated, MBIA Incorporated

    6. May 6, 2013 |Story| Reuters

  6. U.S. RESEARCH ROUNDUP: Apple, Berkshire Hathaway, Walt Disney, AIG

    Reuters
    May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Berkshire Hathaway and Walt Disney, on Monday. HIGHLIGHTS * Apple : Barclays ups target price to $525 from $465; rating...

    Tags: Keycorp, Bio-Rad Laboratories Incorporated, Deutsche Bank AG, AOL LLC, Citigroup Incorporated

    7. Apr 26, 2013 |Story| Reuters

  7. EU agency backs new Roche, Astellas, Sanofi, Vivus drugs

    Reuters
    LONDON, April 26 (Reuters) - European regulators have recommended approval of two new cancer drugs, called Erivedge and Xtandi, from Roche and Astellas. The European Medicines Agency said on Friday its experts had also backed MAC1, a tissue-engineered...

    Tags: Drugs and Medicines

    8. Jul 17, 2012 |Story| CNN
  8. |Story

    Tags: Pharmaceuticals, Weight Loss, Trials, Health Treatments, Sports

    9. Apr 30, 2012 |Story| South Florida Sun-Sentinel

  9. Nuevo rival para el Viagra

    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer Inc.
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...

    Tags: Levitra (drug), Cialis (drug), Drugs and Medicines, Pfizer Inc., Health

    10. Mar 29, 2012 |Story| Reuters

  10. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Weight Loss, Stroke, Trials, Drug Trafficking, Diabetes

    11. Feb 23, 2012 |Story| Reuters
  11. |Story
    12. Feb 23, 2012 |Story| Reuters
  12. |Story
 1  2 • Next >
Original site for Vivus Inc. topic gallery.